Contractor intelligence · computed from public award records
EVAPHARMA
- Awards won
- 35
- Known value
- USD 3.6M
- First award
- 11 Nov 2018
- Most recent
- 21 Oct 2019
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 35 | USD 3.6M | 21 Oct 2019 |
Where the work is
EG · 35
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- procurement of hepatitis C drugs · 21 Oct 2019 · USD 102K · World Bank
- Procurement of hepatitis C drugs · 21 Oct 2019 · USD 102K · World Bank
- Procurement of hepatitis C drugs · 21 Oct 2019 · USD 101K · World Bank
- Procurement of Hepatitis C drugs · 21 Oct 2019 · USD 101K · World Bank
- procurement of hepatitis C drugs · 21 Oct 2019 · USD 101K · World Bank
- This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir. · 21 Oct 2019 · USD 101K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 106K · World Bank
- Purchase of hepatitis C drugs · 22 Jul 2019 · USD 110K · World Bank
- Purchase of hepatitis c drugs · 22 Jul 2019 · USD 108K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 106K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 106K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 105K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 106K · World Bank
- all technical offers are acceptable The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 95K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 95K · World Bank
Method
Computed from 35 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.